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Abstract
Study Design: Analysis of a prospective 2-center database.
Objectives: Medical comorbidities co-determine clinical outcome. Objective functional impairment (OFI) provides a supple-
mentary dimension of patient assessment. We set out to study whether comorbidities are associated with the presence and
degree of OFI in this patient population.
Methods: Patients with degenerative diseases of the spine preoperatively performed the timed-up-and-go (TUG) test and a
battery of questionnaires. Comorbidities were quantified using the Charlson Comorbidity Index (CCI) and the American Society
of Anesthesiology (ASA) grading. Crude and adjusted linear regression models were fitted.
Results: Of 375 included patients, 97 (25.9%) presented at least some degree of medical comorbidity according to the CCI, and
312 (83.2%) according to ASA grading. In the univariate analysis, the CCI was inconsistently associated with OFI. Only patients
with low-grade CCI comorbidity displayed significantly higher TUG test times (p¼ 0.004). In the multivariable analysis, this effect
persisted for patients with CCI ¼ 1 (p ¼ 0.030). Regarding ASA grade, patients with ASA ¼ 3 exhibited significantly increased
TUG test times (p ¼ 0.003) and t-scores (p ¼ 0.015). This effect disappeared after multivariable adjustment (p ¼ 0.786 and
p ¼ 0.969). In addition, subjective functional impairment according to ODI, and EQ5D index was moderately associated with
comorbidities according to ASA (all p < 0.05).
Conclusion: The degree of medical comorbidities appears only weakly and inconsistently associated with OFI in patients
scheduled for degenerative lumbar spine surgery, especially after controlling for potential confounders. TUG testing may be valid
even in patients with relatively severe comorbidities who are able to complete the test.
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Introduction
During the past decades, outcome of interest in medical
research have shifted from surrogate measures of success such
as radiological parameters and physician-based outcome
assessment toward subjective patient-reported outcome mea-
sures (PROMs).1 Recently, frequently used subjective mea-
sures of success (e.g. PROMs such as the Oswestry Disability
Index [ODI]) have been complemented by objective functional
testing, through which the presence and degree of objective
functional impairment (OFI) can be evaluated.2-4 These tests4
include the timed-up-and-go (TUG),2 6-minute-walking
(6WT),5 or 5-repetition sit-to-stand (5R-STS).3 Their aim is
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to capture symptoms and signs that cannot be registered by
well-established PROMs, such as mobility restrictions result-
ing from foot drop and limping.6,7Overall, the quick execution,
high reliability and straight-forward interpretation of OFI tests
have the potential to be of great benefit when used alongside
PROMs.8-11
Medical comorbidities such as chronic-obstructive pulmon-
ary disease (COPD), cardiovascular disease, diabetes mellitus,
asthma, morbid obesity or malnutrition among others are not
uncommon in patients scheduled for surgery for lumbar degen-
erative disc disease (DDD).12,13 These are possibly linked to
sarcopenia,14 functional dependency,15 discharge disposition,16
postoperative delirium,17 higher onset of post-operative com-
plication18-20 and mortality rates.18-21 Overall, they contribute
to a poorer functional status and TUG performance in norma-
tive populations.22,23 Other tests for OFI like the 5R-STS are
even commonly used to grade comorbidity, e.g. in COPD.24 A
strong influence of medical comorbidities on TUG test perfor-
mance would mean that—in the presence of severe comorbid-
ities such as COPD—any amount of OFI could also just as well
be explained by the comorbidity instead of DDD, and would
thus lower the value of objective functional testing. The asso-
ciation of medical comorbidities with OFI as assessed by the
TUG is not yet scientifically investigated.2
The goal of this study consequently was to quantify the
extent of association among medical comorbidities and OFI




This study was a secondary analysis of a prospective 2-center
database. The study was approved by the Institutional Review
Board (IRB) of the University of Geneva (IRB No. 14-079) and
the Ethics Committee St.Gallen (IRB No. 14/049). All patients
gave written informed consent. All objective functional testing
took place during preoperative consultations.
Study Population
All enrolled patients were candidates for elective surgery. They
were assessed preoperatively during outpatient consultations or
upon admission for surgical treatment. Inclusion criteria were
the presence of lumbar disc herniation (LDH), lumbar spinal
stenosis (LSS), or any type of lumbar DDD requiring surgical
treatment. Only patients 18 years or older were included. Preg-
nant patients or those with severe functional disability unre-
lated to the spine disease but unable to walk and perform the
TUG test were excluded.
Baseline Variables
Alongside objective functional testing, a battery of PROMs
were collected as stated previously.2 Specifically, patients were
asked to complete questionnaires containing baseline
sociodemographic data, as well as numeric rating scales: visual
analogue scale (VAS) for back and leg pain severity, validated
German and French versions of the Oswestry Disability Index
(ODI), Roland-Morris Disability Questionnaire (RMDQ), the
Short-Form 12 questionnaire physical component summary
score (SF12 PCS), and EuroQOL-5D (EQ-5D) question-
naire—containing the EQ-5D index and visual analogue scale
(EQ-VAS).
Medical comorbidities were quantified by neurosurgeons
and anesthesiologists using standardized protocols according
to the Charlson Comordbidity Index25 (CCI) and the American
Society of Anesthesiology (ASA) grading,26 respectively. The
CCI allows for robust estimates of mortality from comorbid
disease by assigning 1, 2, 3 or 6 points for a standardized list
of comorbidities (see Supplementary Material 1). The ASA
grading stratifies patients into normal/healthy (ASA 1), into
those with mild (ASA 2) or severe systemic disease (ASA 3).
Those graded higher are in constant threat to life (ASA 4), are
not expected to survive without (ASA 5) or even with the
intended surgical procedure (ASA 6).
The Timed-Up-and-Go (TUG) Test
All patients performed the TUG test as described previously.2
In brief, on the words “Three, Two, One—Go!” patients got up
from a chair with an arm rest, walked as fast as possible (with-
out running) to a line in 3-m distance. Then, they would turn
around by 180 and return—again, as fast as possible—to the
chair and sit down. The time between getting up from the chair
and sitting back down was recorded using the “TUG app.”10
Patients were encouraged to wear their regular shoes and use a
walking aid, if required. Raw TUG test times (in seconds) were
transformed into OFI T-scores, based on age- and sex-adjusted
normative data, with T-scores > 123 representing values that
exceed the 99th percentile of the normal population and are
thus indicative of OFI.2 T-scores indicate how much a numer-
ical value deviates from the population mean. As a transforma-
tion of Z-scores—the number of standard deviations that a
value deviates from the population mean—T-scores are easier
to compare with other tests, and were derived according to
Gautschi et al.2
Statistical Analysis
Continuous variables are reported as means + standard
deviations (SD), and categorical variables as numbers and
percentages. The severity of OFI at baseline was graded
according to the previously described severity stratifica-
tion.2,11 Levene’s test was used to check for equality of var-
iance. We assessed intergroup differences using 1-way
analysis of variance (ANOVA). Subsequently, linear regres-
sion models were fitted to evaluate the influence of the sever-
ity grading on TUG performance, with CCI¼ 0 or ASA¼ 1 as
the reference category. Crude and multivariate regression
models, adjusted for age, sex, body mass index, paresis, sur-
gical procedure, and index level were constructed to correct
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for potential confounders.3,11,27 The assumptions of the gen-
eralized linear models were evaluated, and the model fit was
quantified by R2 values. All analyses were carried out in R
version 3.5.1 (The R Foundation for Statistical Computing,
Vienna, Austria).28 A p  0.05 on 2-tailed tests was consid-
ered statistically significant. The statistical code (Supplemen-
tary Material 2) is attached. The statistical analysis was
cross-checked with an external biostatistician.
Results
Patient Population
A total of 375 patients were included. There was no missing
data. Detailed baseline patient characteristics are provided in
Table 1. On average, included patients were 58.9 + 15.7
years old, with 162 (43.2%) being female. The majority of
patients had index pathologies on a single spinal level
(86.1%), most commonly at L4-L5 (46.1%), and most fre-
quently presenting with LDH requiring discectomy (50.4%).
In terms of medical comorbidities, 278 patients (74.1%) pre-
sented without comorbidity according to the CCI, and 63
patients (16.8%) presented with ASA Grade I, signifying
absence of systemic comorbidities.
Association of CCI With TUG/OFI
Univariable analysis. Detailed results are provided in Tables 2
and 3. Raw TUG test times were unevenly distributed among
the various CCI classes (p ¼ 0.004), increasing inconsistently
from 10.62 + 5.94 seconds for CCI ¼ 0 to 13.27 + 6.39
seconds for CCI ¼ 4. In particular, CCI ¼ 1 demonstrated
markedly increased TUG test times with 15.15 + 15.65 sec-
onds (Figure 1). However, there was no significant associa-
tion among TUG t-scores and CCI (p ¼ 0.336). In univariable
regression analysis, compared to CCI ¼ 0, only patients with
CCI ¼ 1 demonstrated significantly different TUG test times
(regression coefficient [RC]: 4.54, 95% confidence interval
[CI]: 2.25 to 6.82, p < 0.001), and there was no influence of
CCI on TUG t-scores.
Multivariable analysis. Table 3 details the results of the multi-
variate regression analysis. Corroborating the univariable anal-
ysis, only patients with mild systemic comorbidity (CCI ¼ 1)
exhibited higher TUG test times (RC: 13.11, 95% CI: 1.73 to
24.49, p ¼ 0.030) after correcting for potential confounders.
The same effect was now replicated in terms of TUG t-scores
(RC: 105.07, 95% CI: 11.66 to 198.48, p ¼ 0.034).
Association of ASA Score With TUG/OFI
Univariable analysis. Detailed results are provided in Tables 2
and 3. Patients with ASA ¼ 3 demonstrated a significantly
increased TUG test times (15.53 + 18.10 seconds, p ¼
0.003) compared to ASA¼ 1 (11.25+ 8.68 seconds) and ASA
¼ 2 (10.82+ 5.22 seconds). While ASA grading was weakly
associated with TUG t-scores overall (p ¼ 0.015), no clear and
consistent pattern was distinguishable, with ASA ¼ 2 demon-
strating markedly lower t-scores. In univariable regression
analysis, these patterns were replicated: Concerning TUG test
time, patients with ASA ¼ 3 demonstrated increased test times




Age [yrs] 58.9 + 15.7
Female sex, n (%) 162 (43.2)





BMI [kg/m2] 27.1 + 4.6
Active smoker, n (%) 96 (25.6)
Paresis, n (%) 102 (27.2)


































Continuous variables are presented as mean+ SD and categorical variables as
frequency (percentage).
BMI, body mass index; ASA, American Society of Anesthesiologists; BMRC,
British medical research council.
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Table 2. Baseline Measures of Objective Functional Impairment and Subjective Patient-Reported Questionnaires Stratified by the Presence and
Degree of Comorbidities.
Charlson Comorbidity Index 0 1 2 3 4 P Value
TUG test time [s] 10.62+ 5.94 15.15+ 15.65 10.75+ 4.58 12.22+ 6.86 13.27+ 6.39 0.004*
TUG t-score 128.08+ 40.37 143.89+ 125.91 117.51+ 17.57 119.67+ 20.75 118.14 + 20.37 0.336
RMDQ 11.58+ 5.25 12.55+ 5.26 10.67+ 4.59 11.78+ 7.33 7.33+ 5.51 0.328
ODI 48.44+ 17.80 51.79+ 16.96 54.00+ 18.52 51.44+ 24.81 58.67+ 12.06 0.374
VAS back pain 3.88+ 2.78 3.47+ 2.51 3.86+ 2.86 5.33+ 3.20 4.33+ 4.04 0.412
VAS leg pain 5.09+ 2.81 4.77+ 2.90 4.55+ 2.93 3.61+ 2.81 5.17+ 1.89 0.496
EQ5D Index 0.51+ 0.22 0.46+ 0.24 0.64+ 0.20 0.55+ 0.20 0.43+ 0.05 0.037*
EQ5D VAS 52.19+ 20.44 51.17+ 20.66 51.52+ 20.17 52.78+ 21.08 65.00+ 8.66 0.851
SF12 PCS 31.31+ 8.16 29.48+ 7.11 29.10+ 8.79 32.33+ 10.79 21.63+ 4.83 0.097
ASA Score 1 2 3 P Value
TUG 11.25+ 8.68 10.82+ 5.22 15.53+ 18.10 0.003*
TUG t-score 143.05+ 66.16 123.96+ 27.23 146.73+ 149.02 0.015*
RMDQ 12.19+ 5.31 11.28+ 5.22 13.20+ 5.33 0.054
ODI 48.00+ 18.47 48.73+ 18.18 55.98+ 13.53 0.032*
VAS back pain 3.04+ 2.47 3.99+ 2.81 4.16+ 2.66 0.035*
VAS leg pain 4.93+ 2.44 5.01+ 2.93 4.77+ 2.75 0.858
EQ5D Index 0.52+ 0.22 0.52+ 0.22 0.42+ 0.21 0.029*
EQ5D VAS 49.05+ 21.87 52.56+ 19.90 53.60+ 20.93 0.408
SF12 PCS 31.78+ 8.13 30.97+ 8.41 28.57+ 5.78 0.108
Continuous variables are presented as mean + SD and categorical variables as frequency (percentage).
TUG, timed up and go; VAS, visual analogue scale; RMDQ, Roland-Morris Disability Questionnaire; ODI, Oswestry Disability Index; SF12, short form 12
questionnaire; PCS, physical component summary; ASA, American Society of Anesthesiologists.
* p  0.05.
Table 3. Uni- and Multivariable Linear Regression Models Describing the Relationship Between Comorbidities and TUG Performance.
Univariate analysis Multivariate analysis
Variable RC 95% CI P value RC 95% CI P value
Charlson Comorbidity Index
TUG test time
0 Reference - - Reference - -
1 4.54 2.25 to 6.82 < 0.001* 13.11 1.73 to 24.49 0.030*
2 0.14 3.59 to 3.86 0.943 6.18 27.20 to 14.84 0.568
3 1.61 3.97 to 7.18 0.573 7.21 28.11 to 13.69 0.504
4 2.65 6.90 to 12.20 0.587 9.82 21.03 to 40.67 0.537
TUG t-score
0 Reference - - Reference - -
1 15.81 1.26 to 32.89 0.070 105.07 11.66 to 198.48 0.034*
2 10.57 38.44 to 17.30 0.458 82.37 254.93 to 90.18 0.356
3 8.40 50.11 to 33.31 0.693 68.78 240.32 to 102.77 0.437
4 9.93 81.42 to 61.55 0.786 73.06 180.17 to 326.30 0.575
ASA Score
TUG test time
1 Reference - - Reference - -
2 0.43 2.74 to 1.88 0.714 5.47 30.84 to 19.90 0.675
3 4.28 1.06 to 7.50 0.010* 3.83 23.66 to 31.32 0.786
TUG t-score
1 Reference - - Reference - -
2 19.09 36.20 to 1.98 0.029* 78.34 287.56 to 130.89 0.468
3 3.67 20.17 to 27.52 0.763 4.55 231.28 to 222.18 0.969
Regression coefficients (RCs) are presented for each degree of comorbidity, compared to no comorbidity. Multivariate analysis is adjusted for age, sex, body mass
index, paresis, procedure, and index level.
TUG, timed up and go test; RC, regression coefficient; CI, confidence interval; ASA, American Society of Anesthesiologists; * p  0.05.
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(RC: 4.28, 95% CI: 1.06 to 7.50, p ¼ 0.010) compared to ASA
¼ 1. Concerning TUG t-scores, patients with ASA ¼ 2 demon-
strated markedly lower t-scores (RC: 19.09, 95% CI: 36.20
to 1.98, p ¼ 0.029).
Multivariable analysis.After correction for potential confounders,
an effect of medical comorbidities on both TUG test times as
well as on TUG t-scores was not discernable.
Association of Comorbidity With PROMs
Table 2 displays univariable analysis of the association among
CCI or ASA grading and various PROMs of pain, disability and
HRQOL. In terms of CCI, only the EQ5D index exhibited a
weak association (p ¼ 0.037) that was, however, inconsistent.
All other PROMswere not correlated to CCI grading. In terms of
ASA score, ODI (p ¼ 0.032), VAS back pain (p ¼ 0.035), and
EQ5D index (p ¼ 0.029) showed weak but statistically signifi-
cant and directionally consistent changes among ASA grades.
Discussion
The current investigation identified some weak and inconsis-
tent associations between medical comorbidities (graded
according to the CCI or ASA scores) and OFI (as defined by
age- and sex-adjusted TUG test results). Patients with lower
CCI scores (see Supplemental Material 1) demonstrated signif-
icantly higher levels of OFI. This was true even after adjust-
ment for confounders. Our data imply that the extent of medical
comorbidities is weakly and inconsistently associated with
TUG test performance in patients scheduled for degenerative
lumbar spine surgery, especially after controlling for potential
confounders. This would in turn suggest that—in this specific
spinal patient population—TUG performance is for the greatest
part explained by disease severity rather than by comorbidities
alone. Thus, TUG testing may be valid even in patients with
relatively severe comorbidities able to complete the test.
To the best of our knowledge, this is the first study investi-
gating association of medical comorbidities with objective
functional testing in patients suffering from lumbar DDD. In
a previous publication from the same cohort, we found that
mental comorbidities such as depression do not influence TUG
test performance.29 In addition, the TUG test appears to be
relatively inert concerning age,30 gender,31 smoking status,32
and body mass index.33 Similarly, it has been established that
5R-STS test performance is only marginally influenced by
these variables in a consistent and predictable way.3,9
Figure 1. Boxplots demonstrating baseline Timed-Up-and-Go (TUG) performance stratified by medical comorbidities. Both raw TUG test
times (top panel) as well as TUG t-scores (bottom panel) are represented. Shown are median values (horizontal line), interquartile ranges
(boxes), range (whiskers) and extreme outliers (circles).
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Consequently, test performance can be adjusted for common
variables such as age and gender, for example by generating t-
scores normalized to a normative population as has been done
with the TUG test for age and gender.2
A reliable and valid test to grade disease severity objectively
should be inert to common confounders, or at least easily adjus-
table for those confounders assuming they affect test perfor-
mance. In degenerative spine surgery, a test for OFI can only be
a reliable outcome measure if the influence of degenerative
spinal disease on TUG performance is far greater than that of
medical comorbidities. With the ever-increasing age of the
world’s population, and especially of the population under-
going degenerative spine surgery, the incidence of medical
comorbidities has been rising and will inevitably continue to
do so in the foreseeable future.12,34
While there are currently no studies investigating medical
comorbidities in patients with spine disease, Kear et al.22 ana-
lyzed a normative population of 200 participants aged from 20
to 59 years, and found that medical comorbidities were asso-
ciated with slower TUG times. In 432 older adults, Nevill
et al.23 even found that the TUG test was the only variable able
to identify individuals at risk of developing medical comorbid-
ities in the future. Based on this evidence, there is at least some
association among medical comorbidities and TUG test perfor-
mance in normative populations.
The present study identified a weak association among ASA
grade 3 and TUG performance (univariate), which consistently
disappeared in the multivariable analysis. The most likely
explanation is that patients with ASA grade 3 were signifi-
cantly older, which was the case in our cohort. By controlling
for age and other potential confounders, we were thus able to
show that there is no apparent direct influence of comorbidity
as graded by ASA on TUG performance.
Interestingly, concerning comorbidities as described by the
CCI, we found that patients with minor comorbidities that add
up to 1 point in the CCI performed slightly worse than those
patients without comorbidities or those with severe comorbid-
ities. This effect persisted in the multivariable analysis and is
thus evidently not explained by one of the potential confoun-
ders controlled for. While not analyzed in this paper, the most
likely potential explanation for this phenomenon is that some
subsets of the comorbidities that add only 1 point to the CCI
(e.g. history of a cerebrovascular ischemia, chronic cognitive
deficits, COPD, congestive heart failure, dementia) may influ-
ence TUG test performance to a greater extent than those that
commonly provide 2 or more points (e.g. complicated diabetes
mellitus, chronic kidney disease, chronic leukemia, acquired
immune deficiency syndrome [AIDS]). This would correspond
to prior evidence that the TUG may be a somewhat sensitive
marker of some of the abovementioned comorbidities such as
cerebrovascular ischemia,35 COPD,36 and dementia.37 It must
be acknowledged that our cohort did not include many patients
with such comorbidities and that these were not specifically
analyzed, and that the association observed among lower-grade
medical comorbidities according to the CCI and TUG test per-
formance was weak in the multivariable analysis.
It could easily be hypothesized that paper-based question-
naires such as PROMs may be much less prone to bias due to
medical comorbidities than functional tests. However, our data
indicate that even questionnaires are at least influenced to a
minor extent by medical comorbidities. We found that ODI,
VAS back pain, and EQ5D index were all weakly but statisti-
cally significantly and directionally consistently increasing
with each ASA grade. As this article focused on the relatively
new objective functional evaluation by the TUG test, we did
not conduct multivariate analyses for each of the PROMs and
hence there is a possibility that the observed relationship
between medical comorbidities and PROM results may also
be biased by patient- or disease-specific variables including
age, sex, body mass index, or disease type and site.
Strengths & Limitations
Strengths of this analysis include the prospective collection of a
fairly large dataset with the source data originating from 2
major Swiss hospitals with catchment areas that span across
different cultural & linguistic regions, which increases the gen-
eralizability of the findings. Besides the application of a rela-
tively novel “objective outcome measure” (TUG test), the
dataset contained various well-established PROM question-
naires without any missing data.
Some limitations apply and should be mentioned. Due to
inclusion of various spinal pathologies, our results cannot be
applied specific to any of the studied disease but should rather
be regarded as a description of effects in the general population
of patients suffering from lumbar DDD. As the majority of
patients presented with LDH, the results are closest to
“disease-specific” for LDH patients. Ideally, further disease-
specific analyses should be conducted to validate and confirm
the present findings. The same can be said for particular med-
ical comorbidities. To preserve statistical power and to objec-
tively and reproducibly collect data on comorbidities, we used
the ASA classification as well as the CCI, which summarize the
impact of comorbidities roughly. However, this precludes any
conclusions on the influence of specific comorbidities such as
e.g. congestive heart failure or COPD on TUG test perfor-
mance, as these were not analyzed. Here, this information was
not collected and the sample size available for such subgroup
analyses would not be sufficient. Additionally, the apparently
high statistical power for this study requires a word of caution,
as some of the revealed statistically significant relationships
may not be of clinical relevance. For this reason, the confidence
intervals of the regression coefficients should be regarded as
more informative than the respective p values. Similarly, sta-
tistical power for the higher CCI scores was comparatively low
as the majority of patients presented with CCI ¼ 0 or CCI ¼ 1.
Lastly, our results may be biased by the fact that the majority of
patients consumed analgesic medications on the daily at base-
line assessment. The exact influence of analgesic medication
on OFI currently remains unknown.4 It should also be noted
that not all confounders may have been accounted for, for
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example psychological factors such as depression, anxiety, and
motivation.
Despite these limitations, our data allow a cautious first
glance at the interplay among medical comorbidities and objec-
tive functional test performance, and suggest that their effect
magnitude on TUG test performance is rather weak when com-
pared to the influence of other variables, especially after con-
trolling for potential confounding variables. TUG testing may
be valid even in patients with comorbidities, provided patients
are able to complete the test safely.
Conclusions
The extent of medical comorbidities appears to be only weakly
and inconsistently associated with OFI (as assessed by the TUG
test) in patients scheduled for degenerative lumbar spine sur-
gery, especially after controlling for potential confounders.
Thus, results of the TUG test may be valid to estimate func-
tional impairment, even in patients with mild, moderate, or
severe comorbidities. Analysis of external cohorts is warranted
to further study the influence of specific medical comorbidities
on OFI in general and in more defined patient populations.
Acknowledgments
The authors are grateful to all participating patients.
Declaration of Conflicting Interests
The author(s) declared the following potential conflicts of interest
with respect to the research, authorship, and/or publication of this
article: The authors declare that the article and its content were com-
posed in the absence of any commercial or financial relationships that
could be construed as a potential conflict of interest.
Funding
The author(s) received no financial support for the research, author-
ship, and/or publication of this article.
ORCID iD
Victor E. Staartjes, BMed https://orcid.org/0000-0003-1039-2098
Holger Joswig, MD/FEBNS https://orcid.org/0000-0003-3540-3
910
Martin N. Stienen, MD/FEBNS https://orcid.org/0000-0002-6417-
1787
Grants and Support
This research did not receive any specific grant from funding agencies
in the public, commercial, or not-for-profit sectors.
Supplemental Material
Supplemental material for this article is available online.
References
1. Falavigna A, Dozza DC, Teles AR, et al. Current status of world-
wide use of patient-reported outcome measures (PROMs) in spine
care. World Neurosurg. 2017;108:328-335. doi:10.1016/j.wneu.
2017.09.002
2. Gautschi OP, Smoll NR, Corniola MV, et al. Validity and relia-
bility of a measurement of objective functional impairment in
lumbar degenerative disc disease: the timed up and go (TUG)
test. Neurosurgery. 2016;79(2):270-278. doi:10.1227/NEU.
0000000000001195
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